# Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)

> **NCT00687245** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 40 (actual)

## Conditions studied

- Endoscopically-Proven GERD
- Reflux

## Interventions

- **DRUG:** esomeprazole magnesium

## Key facts

- **NCT ID:** NCT00687245
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2008-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00687245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00687245, "Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00687245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*